BioBoard
•  Japanese Patients Received Fetal Cell Transplant in China
•  Pig Cholera Outbreak at Kyodo Farm
•  International Accreditation for CSIRO Lab
•  Edison Sheep: Tungsten Wool for Your Bulb

Industry Watch
•  AustCancer's Revisys Supplements Coming to Singapore
•  CSL To Distribute Acrux's MDTS for Female Testosterone Treatment
•  Novogen's Cardiovascular Drug Enters Human Clinical Trial
•  New Nerve Pain Drug From Xenome Enter Human Clinical Trials
•  Ocimum Licensed Biotracker to ARIUS Research
•  CyGenics Renewed NIH Contract on T Cell Technology
•  Sinomem Ties Up with Local University in Membrane Work
•  SciGen to Market SciLin in India
•  Indian Biotech Industry Needs More Mature Funding
•  Lupin to Shut Down Its South African Subsidiary
•  Life Therapeutics and UK BioProducts in Negotiation for Anti-D Product
•  Rockeby's CANDIA5 Completed FDA 510K Trial

Products/Services Highlight
•  Zenosis Launches Two New Titles for Professionals Involved in Clinical Trials
•  Nucleic Acid Solutions Facilitator: Proligo Singapore

Research Findings
•  A Leap in Muscle Wasting Research

Rules & Regulations
•  Indian Biotech Industry Wants a Total Change in GEAC Regime

Agriculture
•  Hybrid Seed System for Wheat Available
•  Indian Researchers Develop New Variety of Finger Millet
•  Forthcoming National Science Facilities in NZ

Commentaries & Analyses
•  The Impact of SARS on The United States Economy

General News
•  Government Effort to Cheaper AIDS Drugs and More Education in China
•  TV Indulgence: Are Your Kids at Risk?
•  The Biomedical Sciences in Singapore Shows Growth Results

People
•  DNA Pioneer Francis Crick Passed Away

Conference Calendar
•  HealthWorlds Asia 2004